Venetiana Panaretou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Venetiana Panaretou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Antonis Louizos
Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece
1 shared publicationIoannis Papazoglou
Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece
1 shared publicationIrene Kouroukli
Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece
1 shared publicationVasiliki Tsekoura
Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece
1 shared publicationVasilios Zompolas
Anesthesiology Department and Pain Clinic, Hippokration General Hospital of Athens, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 1 October 2013
- Published by Wolters Kluwer Health in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 29 (4) , 485-490
Comparison between lornoxicam quick-release and parecoxib for post-operative analgesia after laparoscopic cholecystectomy: A prospective randomized, placebo-controlled trial
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are valuable for post-operative pain as they reduce the use of opioids. Cyclooxygenase-2 inhibitors and traditional NSAIDs can be used. This is a prospective, randomized, placebo-controlled trial to study the efficacy and the safety of the oral administration of lornoxicam quick release tablets versus intravenously administered parecoxib for the management of pain after laparoscopic cholecystectomy (LC). Materials and Methods: One hundred and eight patients, American Society of Anesthesiologists I-II, were randomized to either group A ( n = 36): Lornoxicam quick-release 8 mg PO, group B ( n = 36): Parecoxib 40 mg intravenous (IV) or group C ( n = 36) placebo, for post-operative analgesia, 30 min before the operation and 12 and 24 h post-operatively. All patients received a standard dose of meperidine 1 mg/kg intramuscularly before the incision and post-operatively as rescue analgesia, when visual analog scale (VAS) pain score was P = 0.001). The average dose of meperidine administered was significantly higher in the placebo group, both at 20 min ( P = 0.013/0.007) and 24 h ( P = 0.037/0.023) post-operatively. VAS scores and meperidine requirements were similar in patients who received lornoxicam or parecoxib. Conclusions: Parecoxib 40 mg IV and lornoxicam quick-release 8 mg PO every 12 h are equivalent adjuvant analgesics with a greater efficacy than placebo for post-operative analgesia in patients undergoing LC.
- 1 October 2013
- Published by Wolters Kluwer Health in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 29 (4) , 485-490
Open AccessComparison between lornoxicam quick-release and parecoxib for post-operative analgesia after laparoscopic cholecystectomy: A prospective randomized, placebo-controlled trial
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are valuable for post-operative pain as they reduce the use of opioids. Cyclooxygenase-2 inhibitors and traditional NSAIDs can be used. This is a prospective, randomized, placebo-controlled trial to study the efficacy and the safety of the oral administration of lornoxicam quick release tablets versus intravenously administered parecoxib for the management of pain after laparoscopic cholecystectomy (LC). Materials and Methods: One hundred and eight patients, American Society of Anesthesiologists I-II, were randomized to either group A ( n = 36): Lornoxicam quick-release 8 mg PO, group B ( n = 36): Parecoxib 40 mg intravenous (IV) or group C ( n = 36) placebo, for post-operative analgesia, 30 min before the operation and 12 and 24 h post-operatively. All patients received a standard dose of meperidine 1 mg/kg intramuscularly before the incision and post-operatively as rescue analgesia, when visual analog scale (VAS) pain score was P = 0.001). The average dose of meperidine administered was significantly higher in the placebo group, both at 20 min ( P = 0.013/0.007) and 24 h ( P = 0.037/0.023) post-operatively. VAS scores and meperidine requirements were similar in patients who received lornoxicam or parecoxib. Conclusions: Parecoxib 40 mg IV and lornoxicam quick-release 8 mg PO every 12 h are equivalent adjuvant analgesics with a greater efficacy than placebo for post-operative analgesia in patients undergoing LC.